Marion Biotech

Marion Biotech is a privately held pharmaceutical company based in Noida, India, that focuses on the manufacture and export of generic medicines and healthcare products. The company's portfolio spans several therapeutic areas, including respiratory health, gastroenterology, and pain management, with products such as cough syrups, analgesics, and anti-infectives. Marion Biotech primarily serves international markets in Central Asia, Southeast Asia, and Africa. In late 2022, the company became the subject of global concern after its cough syrups were linked to a series of child fatalities in Uzbekistan, leading to a World Health Organization (WHO) medical product alert. Following these events, Indian regulatory authorities suspended the company's manufacturing license and initiated legal proceedings.